A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
Clinical trial NCT07723248 · RECRUITING
Trial details
- NCT number
- NCT07723248
- Sponsor
- ORIC Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2028-03-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.